OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Study Identifier
GMA-OAB-113
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
Phase
Phase 4
Sex
Female & Male
Age
18+ years
Protocol Summary
This is a study to evaluate the efficacy and safety of onabotulinumtoxinA (BOTOX®) compared with placebo, in achieving a 100% reduction in urinary incontinence in patients with overactive bladder (OAB) not properly managed with an anticholinergic.
Study Locations
Location
Status
Location
Urologic Clinics of North Alabama
Huntsville, Alabama, United States, 35801
Status
Not applicable
Location
Alaska Urological Institute dba Alaska Clinical Research Center
Anchorage, Alaska, United States, 99503
Status
Not applicable
Location
South Orange County Medical Research Center
Laguna Hills, California, United States, 92653
Status
Not applicable
Location
University of Southern California
Los Angeles, California, United States, 90033
Status
Not applicable
Location
Genesis Research LLC
San Diego, California, United States, 92123
Status
Not applicable
Location
U. Colorado, School of Med.
Aurora, Colorado, United States, 80045
Status
Not applicable
Showing {first} - {last} of {total} Results